CARSON CITY, NV–( EMWNews – April 7, 2008) – VitalCare Diabetes Treatment Centers, Inc.

(PINKSHEETS: VDTI), a Nevada corporation, today announced that Tristan V.

Voth-Stonger, MD has accepted a position as Executive Vice President and

Chief Medical Officer with VitalCare. Dr. Voth-Stonger is a Board

Certified Plastic and Reconstructive Surgeon who specializes in

reconstructive surgery and difficult wound care. Dr. Voth-Stonger

graduated from medical school at Indiana University. Thereafter he went to

Zurich, Switzerland to complete his fellowship in Orthopedic and hand

surgery with a leading hand surgeon, after which he moved to Portland,

Oregon (1973 – 1976) to complete his general surgery training as a

prerequisite for his plastic and reconstructive surgical residency (1976 –

1978) at Albany Medical Center in Albany, NY. From (1978 – 1980) he

completed fellowship training with several world class plastic and

reconstructive surgeons, intermixed with missionary medical work in South

and Central America. He furthered that opportunity as a visiting professor

to Sri Lanka under an appointment from the University of California at

Irvine. He has been in private practice since 1980. Dr. Voth-Stonger, a

Lt. Colonel USAF from (1987 – 1994), served as a Flight Surgeon and

Critical Medical Specialist and is a veteran of Desert Storm Operations.

Mr. Jimmy A. McDougald, CEO and Chairman of VitalCare, stated, “We are

pleased to have such a distinguished Physician on our Corporate Management

Team. Dr. Voth-Stonger’s extensive medical training and expertise combined

with his knowledge of investment banking and business administration will

benefit the Company at many levels.”

Dr. Tristan Voth-Stonger said, “I am excited to be part of VitalCare’s

answer to the treatment of Type 1 and Type 2 diabetes, using the

Intracellular Activation Therapy (iCAT) protocol and FDA approved

micro-dosing intravenous insulin pump. I am grateful for this opportunity

to help VitalCare introduce iCAT so that it becomes available to all

diabetic sufferers throughout North America.”

About VitalCare Diabetes Treatment Centers, Inc.

VitalCare Diabetes Treatment Centers, Inc. is a company specializing in

providing Administrative, Marketing, Business Development, Strategic

Planning, Clinical Oversight and Clinical Management Services to the

Diabetes Healthcare Sector, with an emphasis in bringing “Cutting Edge”

medical devices and healthcare services direct to consumers, focusing on an

emerging FDA approved, US and European Patented technology and treatment

intervention for treating Type 1 and Type 2 Diabetes known as

“Intracellular Activation Therapy (iCAT).”

Safe Harbor Statement: Forward-looking statements in this release with

respect to VitalCare Diabetes Treatment Centers, Inc.’s business, financial

condition and results of operations, as well as matters of timing and the

prospective terms of the transaction described are subject to risks and

uncertainties that could cause actual results to differ materially from

those expressed in the forward-looking statements, including, but not

limited to, certain delays beyond VitalCare Diabetes Treatment Centers,

Inc.’s control with respect to market acceptance of their technology and/or

products, whether financing will be available, the effect of the

application of acquisition accounting policies as well as certain other

risk factors which are and may be detailed from time to time in VitalCare’s

filings with the Securities and Exchange Commission.